This page shows the latest GRI news and features for those working in and with pharma, biotech and healthcare.
Ziylo could help it stay ahead in key insulin franchise. Novo Nordisk is aiming to develop the world’s first glucose responsive insulin (GRI) by acquiring UK biotech start-up Ziylo.
TiGenix’ board is backing the takeover deal, which values the company at 520m (around $630m), and two major shareholders - Gri-Cel and Grifols - have already said they will tender their shares.
Perhaps the most high-profile example of these is the Global Reporting Initiative (GRI), which now has 50 pharmaceutical and biotech companies among its 1, 000-plus registered organisations.
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Patient Digital Participation Award - Ampersand Health. Procurement Support or Service Project of the Year - GRI UK and The Bristol, Weston and Bath Partnership Project (BNSSG).
GRI (previously known as de Poel health care) are the headline sponsor of this acknowledged annual benchmark of healthcare excellence.
GRI (previously known as de Poel health care) are the headline sponsor of this acknowledged annual benchmark of healthcare excellence.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
No results were found
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...